General Counsel of Nurix Therapeutics, Inc. (U.S.: Nasdaq:NRIX), Ring Christine, sells 1,200 shares worth $32,568
According to Nurix Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 11 04:10 PM, company General Counsel, Ring Christine disclosed selling 1,200 shares at a cost of $27.14. At the time of this transaction (Jan 10), this trade was worth $32,568 in total. As of Jan 10, Ring Christine now owns 1,286 shares in total worth about $31,597.02.
For the last few recent trades made by Nurix Therapeutics, Inc. (U.S.: Nasdaq:NRIX) General Counsel, Ring Christine, we have the following information:
- SEC Form 4 filing: Oct 27: Sold 800 shares at the rate of $35.25 per share. Total worth of this trade was $28,200. Total number of shares owned as of Oct 27 were 1,286
- SEC Form 4 filing: Sep 10: Sold 2,000 shares at the rate of $35.93 per share. Total worth of this trade was $71,860. Total number of shares owned as of Sep 10 were 1,286
- SEC Form 4 filing: Sep 07: Sold 3,200 shares at the rate of $35.25 per share. Total worth of this trade was $112,800. Total number of shares owned as of Sep 07 were 1,286
Posted by
George Daniels
on Tuesday January 11 2022, 10:51 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
